Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Tipo de estudo
Intervalo de ano de publicação
2.
J Infect Chemother ; 20(1): 6-8, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24462416

RESUMO

We investigated the frequency of BRO ß-lactamase and its relationship to antibiotic susceptibility profiles and serum susceptibility. Moraxella catarrhalis clinical isolates (n = 197) were collected from patients with respiratory tract infections in Tokyo between November 2004 and April 2005. Phenotypic and genotypic detection of ß-lactamases was performed. The MICs of 6 antibiotics were determined by Etest, and the serum bactericidal assay was conducted by using the culture-and-spot test. Nearly all (192; 97%) of the clinical isolates were ß-lactamase producers; of these, 182 (95%) were bro-1 and 10 (5%) were bro-2 positive. MIC50, MIC90, and geometric mean MICs of penicillin, amoxicillin, cefixime, and clarithromycin for BRO-1 isolates were significantly higher than for BRO-2 isolates. The frequency of intermediate and full serum resistance was significantly higher in BRO-1 isolates than in BRO-2 isolates (P = 0.0056), but not BRO-negative isolates (P = 0.1333). We provide the first evidence that the presence of BRO-1 in M. catarrhalis is associated with reduced susceptibility to clarithromycin and ß-lactam antibiotics, as well as serum non-sensitive (intermediate and resistant).


Assuntos
Anti-Infecciosos/farmacologia , Moraxella catarrhalis/efeitos dos fármacos , Moraxella catarrhalis/enzimologia , Infecções por Moraxellaceae/microbiologia , beta-Lactamases/biossíntese , Humanos , Testes de Sensibilidade Microbiana/métodos , Moraxella catarrhalis/isolamento & purificação , Infecções por Moraxellaceae/tratamento farmacológico , Infecções Respiratórias/tratamento farmacológico , Infecções Respiratórias/microbiologia , beta-Lactamases/análise
3.
Res Microbiol ; 164(3): 236-43, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23257176

RESUMO

Moraxella catarrhalis, an important pathogen in the human respiratory tract, causes otitis media and lower respiratory tract infections. M. catarrhalis outer membrane protein CD (OMPCD) is a major heat-modifiable OMP with demonstrable potential as a vaccine candidate. The gene encoding OMPCD of M. catarrhalis strains was subjected to nucleotide sequence analysis and then inactivated by insertional mutagenesis. The ompCD mutant strains exhibited a modest growth defect in comparison with the wild-type strains. In optical microscopy and scanning/transmission electron microscopy examinations, regarding morphology, the cell size and cell wall of the ompCD mutant strains were significantly larger and thinner, respectively, than those of the wild-type strain. Furthermore, the ompCD mutant strains exhibited significant autoaggregation and increased surface hydrophobicity, in addition to a reduction in the adherence to HEp-2 cells, compared to the wild-type strains. Strains repaired by replacing the mutated ompCD gene exhibited phenotypic characteristics very similar to those of the wild-type strains. These results indicate that M. catarrhalis OMPCD, in addition to its functions related to bacterial growth and adherence to human epithelial cells, plays a very important role in bacterial physiology and pathogenesis, including aspects such as stabilizing bacterial cell morphology and preventing autoaggregation by reducing surface hydrophobicity.


Assuntos
Adesinas Bacterianas/genética , Adesinas Bacterianas/metabolismo , Aderência Bacteriana , Moraxella catarrhalis/citologia , Moraxella catarrhalis/fisiologia , Adesinas Bacterianas/química , Sequência de Bases , Células Hep G2 , Humanos , Interações Hidrofóbicas e Hidrofílicas , Moraxella catarrhalis/genética , Moraxella catarrhalis/metabolismo , Mutagênese Insercional , Mutação , Infecções Respiratórias/microbiologia , Análise de Sequência de DNA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA